The timing could hardly be better: as controversial FDA leader, Vinay Prasad, exits FDA’s CBER and sentiment tilts back toward innovation, GeoVax Labs (NASDAQ: GOVX) has launched formal outreach around future procurement of its GEO‑MVA mpox/smallpox vaccine. The company is effectively telling…